PolyFIL Diagnostics plans EUR 300,000 seed round after EUR 50,000 investment

Genesis Biomed-backed PolyFIL Diagnostics plans to raise a EUR 300,000 seed round to fund quality systems, kit manufacturing, and regulatory engagement for its flow cytometry blood test for colorectal polyps and cancer.